Artificially recombinant H9N2 hypotype influenza virus and its uses
An influenza virus, H9N2 technology, applied in antiviral agents, viruses/phages, medical preparations containing active ingredients, etc., can solve the problems of short immunization period, high vaccine cost, poor adaptability, etc. The effect of improving the quality of vaccines
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0015] The artificially recombined H9N2 subtype influenza virus is the artificially recombined H9 subtype influenza virus A / Harbin / Re-2 / 2003 (H9N2), which has the same characteristics as the H9N2 subtype avian influenza virus A / chicken / Guangxi / 10 / 99 (H9N2) HA and NA genes and six internal genes PB2, PB1, PA, NP, M and NS of influenza virus A / PR / 8 / 34 (H1N1), the deposit number is CCTCC-V200311.
[0016] The above-mentioned artificially recombined H9N2 subtype influenza virus has extensive cross immunity to H9N2 avian influenza virus prevailing in my country, has high-titer chicken embryo adaptability, and has no pathogenicity to chicken and chicken embryo.
[0017] The application of the aforementioned artificially recombined H9N2 subtype influenza virus in vaccines for preventing and treating animal and human H9N2 subtype influenza.
[0018] The invention is an artificially produced H9N2 subtype recombinant influenza virus A / Harbin / Re-2 / 2003 (strain number Re-2), the virus HA ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com